NCT01758055View on ClinicalTrials.gov

Safety Study of Endobronchial Transplantation of Autologous Mesenchymal Stem Cells (MSCs) in Emphysema Patients

PHASE1UnknownINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

January 31, 2014

Conditions
Emphysema
Interventions
BIOLOGICAL

Autologous MSCs transplantation

Autologous mesenchymal stem cells derived bone marrow, bronchoscopy

Trial Locations (1)

021

Masih-Daneshvari Hospital, Tehran

Sponsors

Lead Sponsor

Arda Kiani
All Listed Sponsors
collaborator

Royan Institute

OTHER_GOV

lead

Arda Kiani

OTHER

NCT01758055 - Safety Study of Endobronchial Transplantation of Autologous Mesenchymal Stem Cells (MSCs) in Emphysema Patients | Biotech Hunter | Biotech Hunter